Cutaneous mucormycosis confirmed using a Mucorales-specific monoclonal antibody: a case study
Alyssa C. Hudson, Ben Rymer, Shwetha Pradeep, Jeremy N. Day, Dora E. Corzo-León, Elizabeth R. Ballou, Andrew M. Borman, Christopher R. Thornton · 2026
Read Cutaneous mucormycosis confirmed using a Mucorales-specific monoclonal antibody: a case study by Alyssa C. Hudson, Ben Rymer, Shwetha Pradeep, Jeremy N. Day, Dora E. Corzo-León, Elizabeth R. Ballou, Andrew M. Borman, Christopher R. Thornton (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13194488.txt.
Description
Alyssa Hudson and co-authors confirm a flesh-destroying fungal infection with a tailored antibody test in a 2026 case study. Mucormycosis invades blood vessels and kills tissue fast, yet standard culture is slow and often misses it. Their patient, a healthy man of forty-nine, hurt his hand in a farming accident. The wound looked clean after repeated surgical cleaning, but infection persisted.
The fungus proved to be Lichtheimia ramosa. Diagnosis lagged from low suspicion and from sample grinding that blunted culture. The standard antifungal harmed his kidneys, forcing a switch. He healed with hand function saved. The team then showed an antibody built for this fungal order could flag the infection in ground tissue, as a stain and in a rapid lateral-flow strip. They call for better awareness and faster, sharper tests.
Catalog record
| CREATOR | Alyssa C. Hudson, Ben Rymer, Shwetha Pradeep, Jeremy N. Day, Dora E. Corzo-León, Elizabeth R. Ballou, Andrew M. Borman, Christopher R. Thornton |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 29 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |